Radiopharmaceutical Treatment of Advanced Kidney Cancer
NCT06783348
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
48
Enrollment
NETWORK
Sponsor class
Conditions
Metastatic Clear Cell Renal Cell Carcinoma
Interventions
DRUG:
177Lu-PSMA-617
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
[object Object]